Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT01806571 · COMPLETED
Trial details
- NCT number
- NCT01806571
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-12
- Primary completion
- 2017-07-31
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.